HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 59150509, compound → 2-Ethyl-10-methyl-7-(4-{[4-methyl-5-(2-methyl-5-quinolinyl)-4H-1,2,4-triazol-3-yl]thio}butyl)-6,7,8,9-tetrahydro-5H-[1,3]oxazolo[4,5-h][3]benzazepine hydrochloride
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | HCID 59150509 | HCID 59150509 | — |
| Reactant | HCID 59150537 | HCID 59150537 | — |
| Product | 2-Ethyl-10-methyl-7-(4-{[4-methyl-5-(2-methyl-5-quinolinyl)-4H-1,2,4-triazol-3-yl]thio}butyl)-6,7,8,9-tetrahydro-5H-[1,3]oxazolo[4,5-h][3]benzazepine hydrochloride | HCID 67359488 | — |
Reaction Steps
The title compound was prepared in analogy to General Procedure 1 from 2-ethyl-10-methyl-6,7,8,9-tetrahydro-5H-[1,3]oxazolo[4,5-h][3]benzazepine (85 mg) and 5-{5-[(4-chlorobutyl)thio]-4-methyl-4H-1,2,4-triazol-3-yl}-2-methylquinoline (153 mg) and was obtained as a colourless slightly hygroscopic solid (136 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07989444B2 |
| Source dataset | uspto-grants-2011_08 |
| ORD ID | ord-e4024ea31a254345bbfc0336991f36a7 |
| Source note | uspto-grants-2011_08 |